LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
LB Pharmaceuticals (NASDAQ:LBRX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture [Yahoo! Finance]
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture